Suppr超能文献

雷特格韦在体外人胎盘小叶灌注模型中的双向转运

Bidirectional Transfer of Raltegravir in an Ex Vivo Human Cotyledon Perfusion Model.

作者信息

Vinot Cécile, Tréluyer Jean-Marc, Giraud Carole, Gavard Laurent, Peytavin Gilles, Mandelbrot Laurent

机构信息

EA 3620, Université Paris Descartes, Paris, France Unité de Recherche Clinique Cochin Necker/CIC 0901, Groupe Hospitalier Cochin-Broca-Hôtel Dieu, Assistance Publique-Hôpitaux de Paris, Paris, France Risk in Pregnancy University Department, Paris, France.

EA 3620, Université Paris Descartes, Paris, France Unité de Recherche Clinique Cochin Necker/CIC 0901, Groupe Hospitalier Cochin-Broca-Hôtel Dieu, Assistance Publique-Hôpitaux de Paris, Paris, France Risk in Pregnancy University Department, Paris, France Service de Pharmacologie Clinique, Hôpitaux Universitaires Paris Centre Cochin-Broca-Hôtel Dieu, Assistance Publique-Hôpitaux de Paris, Paris, France.

出版信息

Antimicrob Agents Chemother. 2016 Apr 22;60(5):3112-4. doi: 10.1128/AAC.00007-16. Print 2016 May.

Abstract

Placental transfer of the HIV integrase inhibitor raltegravir (RLT) was investigated in term human cotyledons in the maternal-to-fetal (n = 3) and fetal-to-maternal (n = 6) directions. In the maternal-to-fetal direction, the mean ± standard deviation (SD) fetal transfer rate (FTR) was 9.1% ± 1.4%, and the mean ± SD clearance index (IC), i.e., RLT FTR/antipyrine FTR, was 0.28 ± 0.05. In the fetal-to-maternal direction, the mean ± SD CI was 0.31 ± 0.09. Placental transfer of RLT was high in both directions.

摘要

在足月人胎盘小叶中,研究了HIV整合酶抑制剂拉替拉韦(RLT)在母胎(n = 3)和胎母(n = 6)方向上的胎盘转运情况。在母胎方向上,平均±标准差(SD)的胎儿转运率(FTR)为9.1%±1.4%,平均±SD清除指数(IC),即RLT FTR/安替比林FTR为0.28±0.05。在胎母方向上,平均±SD CI为0.31±0.09。RLT在两个方向上的胎盘转运率都很高。

相似文献

1
Bidirectional Transfer of Raltegravir in an Ex Vivo Human Cotyledon Perfusion Model.
Antimicrob Agents Chemother. 2016 Apr 22;60(5):3112-4. doi: 10.1128/AAC.00007-16. Print 2016 May.
2
Placental transfer of rilpivirine in an ex vivo human cotyledon perfusion model.
Antimicrob Agents Chemother. 2015 May;59(5):2901-3. doi: 10.1128/AAC.00075-15. Epub 2015 Feb 17.
3
Placental transfer of darunavir in an ex vivo human cotyledon perfusion model.
Antimicrob Agents Chemother. 2014 Sep;58(9):5617-20. doi: 10.1128/AAC.03184-14. Epub 2014 Jun 30.
4
Placental transfer and tissue accumulation of dolutegravir in the ex vivo human cotyledon perfusion model.
PLoS One. 2019 Aug 13;14(8):e0220323. doi: 10.1371/journal.pone.0220323. eCollection 2019.
5
Placental transfer of the HIV integrase inhibitor dolutegravir in an ex vivo human cotyledon perfusion model.
J Antimicrob Chemother. 2016 Feb;71(2):480-3. doi: 10.1093/jac/dkv358. Epub 2015 Nov 3.
7
Placental transfer of maraviroc in an ex vivo human cotyledon perfusion model and influence of ABC transporter expression.
Antimicrob Agents Chemother. 2013 Mar;57(3):1415-20. doi: 10.1128/AAC.01821-12. Epub 2013 Jan 7.
9
Differential bidirectional transfer of indinavir in the isolated perfused human placenta.
Antimicrob Agents Chemother. 2005 Mar;49(3):1023-8. doi: 10.1128/AAC.49.3.1023-1028.2005.
10
Maternal-fetal transfer of saquinavir studied in the ex vivo placental perfusion model.
Am J Obstet Gynecol. 2001 Jul;185(1):178-81. doi: 10.1067/mob.2001.113319.

引用本文的文献

2
Antiretroviral Regimen and Pregnancy Outcomes of Women Living with HIV in a US Cohort.
Infect Dis Clin Pract (Baltim Md). 2023 Nov;31(6). doi: 10.1097/IPC.0000000000001308. Epub 2023 Sep 25.
3
HIV-1 Integrase Strand Transfer Inhibitors and Neurodevelopment.
Pharmaceuticals (Basel). 2022 Dec 9;15(12):1533. doi: 10.3390/ph15121533.
4
Ensemble learning for predicting ex vivo human placental barrier permeability.
BMC Bioinformatics. 2022 Sep 22;22(Suppl 10):629. doi: 10.1186/s12859-022-04937-y.
6
Placental transfer and tissue accumulation of dolutegravir in the ex vivo human cotyledon perfusion model.
PLoS One. 2019 Aug 13;14(8):e0220323. doi: 10.1371/journal.pone.0220323. eCollection 2019.

本文引用的文献

1
A case series of third-trimester raltegravir initiation: Impact on maternal HIV-1 viral load and obstetrical outcomes.
Can J Infect Dis Med Microbiol. 2015 May-Jun;26(3):145-50. doi: 10.1155/2015/731043.
2
No perinatal HIV-1 transmission from women with effective antiretroviral therapy starting before conception.
Clin Infect Dis. 2015 Dec 1;61(11):1715-25. doi: 10.1093/cid/civ578. Epub 2015 Jul 21.
3
Raltegravir in HIV-1-Infected Pregnant Women: Pharmacokinetics, Safety, and Efficacy.
Clin Infect Dis. 2015 Sep 1;61(5):809-16. doi: 10.1093/cid/civ366. Epub 2015 May 5.
4
Placental transfer of rilpivirine in an ex vivo human cotyledon perfusion model.
Antimicrob Agents Chemother. 2015 May;59(5):2901-3. doi: 10.1128/AAC.00075-15. Epub 2015 Feb 17.
5
Raltegravir pharmacokinetics during pregnancy.
J Acquir Immune Defic Syndr. 2014 Dec 1;67(4):375-81. doi: 10.1097/QAI.0000000000000318.
6
Placental transfer of darunavir in an ex vivo human cotyledon perfusion model.
Antimicrob Agents Chemother. 2014 Sep;58(9):5617-20. doi: 10.1128/AAC.03184-14. Epub 2014 Jun 30.
7
Earlier initiation of ART and further decline in mother-to-child HIV transmission rates, 2000-2011.
AIDS. 2014 Apr 24;28(7):1049-57. doi: 10.1097/QAD.0000000000000212.
9
Short communication: Use of raltegravir in late-presenting HIV-infected pregnant women.
AIDS Res Hum Retroviruses. 2013 Nov;29(11):1451-4. doi: 10.1089/AID.2013.0059. Epub 2013 Jun 25.
10
Placental transfer of maraviroc in an ex vivo human cotyledon perfusion model and influence of ABC transporter expression.
Antimicrob Agents Chemother. 2013 Mar;57(3):1415-20. doi: 10.1128/AAC.01821-12. Epub 2013 Jan 7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验